| MP 7.01.18 | Percutaneous Discectomy | |
| Medical Policy | ||
| Section Surgery |
Original Policy Date 12/1/95 |
Last Review Status/Date Reviewed with literature search/11:2008 |
| Issue 11:2008 |
Return to Medical Policy Index |
Disclaimer
Our medical policies are designed for informational purposes only and are not an authorization, or an explanation of benefits, or a contract. Receipt of benefits is subject to satisfaction of all terms and conditions of the coverage. Medical technology is constantly changing, and we reserve the right to review and update our policies periodically.
Description
Back pain related to herniated discs is an extremely common condition and a frequent cause of chronic disability. Although many cases of acute low back pain will resolve with conservative care, a surgical decompression is often considered when the pain is unimproved after a month and is clearly neuropathic in origin, resulting from irritation of the nerve roots. Open surgical treatment typically consists of some sort of discectomy, where the extruding disc material is excised. Minimally invasive options have also been researched, in which some portion of the disc material is removed or ablated, although these techniques are not precisely targeted at the offending extruding disc material. Ablative techniques include laser discectomy and radiofrequency decompression (see policy No. 7.01.93 ). In addition, intradiscal electrothermal annuloplasty is another minimally invasive approach to low back pain. In this technique, radiofrequency energy is used to treat the surrounding disc annulus (see policy No. 7.01.72 ).
This policy addresses percutaneous lumbar discectomy (PLD), in which the disc decompression is accomplished by the physical removal of disc material rather than its ablation. Originally, PLD was performed manually, using cutting forceps to remove nuclear material from within the disc annulus. This technique has been replaced with automated devices that involve placement of a probe within the intervertebral disc and aspiration of disc material using a suction cutting device. The Stryker DeKompressor Percutaneous Discectomy Probe (Stryker) and the Nucleotome (Clarus Medical) are examples of percutaneous discectomy devices that received clearance from the U.S. Food and Drug Administration (FDA) through the 510(k) process. Both have the same labeled intended use, i.e., “for use in aspiration of disc material during percutaneous discectomies in the lumbar, thoracic and cervical regions of the spine.”
Policy
Percutaneous discectomy is considered investigational as a technique of intervertebral disc decompression in patients with back pain related to disc herniation in the lumbar, thoracic, or cervical spine
Policy Guidelines
CPT code 62287 specifically describes a percutaneous aspiration or decompression procedure of the lumbar spine. This code does not distinguish between an aspiration procedure (addressed in this policy) and a laser decompression procedure (addressed in policy No. 7.01.93 ). Also note that this code is specifically limited to the lumbar region. Although the majority of percutaneous discectomies are performed on lumbar vertebrae, the FDA labeling of the Stryker DeKompressor Percutaneous Discectomy Probe includes the thoracic and cervical vertebrae.
Benefit Application
Percutaneous discectomy may be performed by surgeons, but anesthesiologists or other physicians whose practices focus on pain management may also perform this procedure.
State or federal mandates (e.g., FEP) may dictate that all FDA-approved devices may not be considered investigational and thus these devices may be assessed only on the basis of their medical necessity.
Rationale
This policy was originally based on a 1990 TEC Assessment, which concluded that percutaneous discectomy met the TEC criteria. Therefore, the original policy concluded that percutaneous discectomy was considered medically necessary in carefully selected patients. This policy statement remained unchanged until 2005. Since the 1990 TEC Assessment, the methodology of evidence-based medicine in general has grown in sophistication. Specifically, it is recognized that that randomized clinical trials are extremely important to assess treatments of painful conditions and low back pain in particular, due both to the expected placebo effect, the subjective nature of pain assessment in general, and also the variable natural history of low back pain that often responds to conservative care. Disc decompression using lasers or radiofrequency energy to ablate disc material is a relatively new minimally invasive technique that is considered an alternative to percutaneous discectomy. Both of these techniques, addressed in policy No. 7.01.93, are considered investigational, in part due to the lack of controlled trials. Therefore, this policy on percutaneous discectomy is reviewed again in 2005, applying the same evidence standard as that used for laser or radiofrequency decompression procedures.
The literature was searched for the period of 1990 to February 2005 with a specific focus on controlled clinical trials comparing percutaneous discectomy to either open discectomy or conservative therapy. The literature search identified a large number of case series, but only 5 controlled trials, of which 4 were reviewed in a 2000 Cochrane report. (1) (All of these controlled trials were published after 1990 and thus were not reviewed as part of the TEC Assessment.) The Cochrane review concluded, “Three trials of percutaneous discectomy provided moderate evidence that it produces poorer clinical outcomes than standard discectomy or chymopapain.” For example, Chatterjee reported on the results of a study that randomized 71 patients with lumbar disc herniation to undergo either percutaneous discectomy or lumbar microdiscectomy. (2) A successful outcome was reported in only 29% of those undergoing percutaneous discectomy compared to 80% in the microdiscectomy group. The trial was halted early due to this inferior outcome. In a 1993 randomized study, Revel and colleagues compared the outcomes of percutaneous discectomy to chymopapain injection in 141 patients with disk herniation and sciatica. (3) Treatment was considered successful in 61% of patients in the chymopapain group compared to 44% in the percutaneous discectomy group. Another trial cited in the Cochrane review, Mayer et al, is not applicable since the technique used modified forceps in addition to a suction probe. (4) Finally, the last trial cited in the Cochrane review, Hermantin et al, provided insufficient data to allow detailed analysis of results. (5)
The only additional controlled study published since the 2000 Cochrane review was the results of the LAPDOG study, a randomized trial designed to compare percutaneous and open discectomy in patients with lumbar disc herniation. (6) This trial was designed to recruit 330 patients, but only was able to recruit 36 patients, for reasons that were not readily apparent to the authors. Of the evaluable 27 patients, 41% of the percutaneous discectomy patients and 40% of the conventional discectomy patients were assessed as having successful outcomes at 6 months. The authors concluded that this trial was unable to enroll sufficient numbers of patients to reach a definitive conclusion. The authors state, “It is difficult to understand the remarkable persistence of percutaneous discectomy in the face of a virtually complete lack of scientific support for its effectiveness in treated lumbar disc herniation.”
All of the trials reviewed here focused on lumbar disc herniation. There were no clinical trials of percutaneous discectomy of cervical or thoracic disc herniation.
Summary
Using a standard of controlled clinical trials to evaluate the safety and effectiveness of percutaneous discectomy, there are inadequate published data to permit scientific conclusions.
2006 Update
A literature search performed for the period of 2005 through January 2006 did not identify any published studies that would prompt reconsideration of the policy statement, which remains unchanged.
2007 Update
A search of the MEDLINE database for the period of February 2006 through July 2007 did not identify any additional controlled trials. Gibson and Waddel published an updated Cochrane review of surgical interventions for lumbar disc prolapse, concluding that there is insufficient evidence on percutaneous discectomy techniques to draw firm conclusions. (7) A task force of the American Society of Interventional Pain Physicians reports that percutaneous disc decompression remains controversial; although all observational studies were positive, the evidence from 4 of 4 randomized published studies was negative. (8) Questions also remain about the appropriate patient selection criteria (particularly related to the size and migration of the disc herniation) for this procedure. (7, 8)
2008 Update
The policy was updated with a search of the MEDLINE database in October 2008. No new relevant studies were identified. Freeman and Mehdian assessed the current evidence for three minimally invasive techniques used to treat discogenic low back pain and radicular pain: electrothermal therapy (IDET), percutaneous discectomy, and nucleoplasty. (9) They report that trials of automated percutaneous discectomy suggest that clinical outcomes are at best fair and often worse when compared with microdisctomy.
References:
- Gibson JNA, Grant IC, Waddell G. Surgery for lumbar disc prolapse. (Cochrane Review). In: The Cochrane Library, Issue 2, 2003. Oxford: Update Software.
- Chatterjee S, Foy PM, Findlay GF. Report of a controlled clinical trial comparing automated percutaneous lumbar discectomy and microdiscectomy in the treatment of contained lumbar disc herniation. Spine 1995; 20(6):734-8.
- Revel M, Payan C, Vallee C et al. Automated percutaneous lumbar discectomy versus chemonucleolysis in the treatment of sciatica. Spine 1993; 18(1):1-7.
- Mayer HM, Brock M. Percutaneous endoscopic discectomy: surgical technique and preliminary results compared to microsurgical discectomy. J Neurosurg 1993; 78(2):216-25.
- Hermantin FU, Peters T, Quartararo L et al. A prospective, randomized study comparing the results of open discectomy with those of video-assisted arthroscopic discectomy. J Bone Joint Surg Am 1999; 81(7):958-65.
- Haines SJ, Jordan N, Boen JR et al. Discectomy strategies for lumbar disc herniation: results of the LAPDOG trial. J Clin Neurosci 2002; 9(4):411-7.
-
Gibson JN, Waddell G. Surgical interventions for lumbar disc prolapse. Cochrane Database Syst Rev 2007; (2):CD001350.
-
Boswell MV, Trescot AM, Datta S et al; American Society of Interventional Pain Physicians. Interventional techniques: evidence-based practice guidelines in the management of chronic spinal pain. Pain Physician 2007; 10(1):7-111.
-
Freeman BJ and Mehdian R. Intradiscal electrothermal therapy, percutaneous discectomy, and nucleoplasty: what is the current evidence? Curr Pain Headache Rep 2008; 12(1):14-21.
|
Codes |
Number |
Description |
|
CPT |
62287 |
Decompression procedure, percutaneous, of nucleus pulposus of intervertebral disk, any method, single or multiple levels, lumbar (e.g., manual or automated percutaneous diskectomy, percutaneous laser diskectomy) |
|
ICD-9 Procedure |
80.59 |
Other destruction of intervertebral disc |
|
ICD-9 Diagnosis |
722.52 |
Degeneration of lumbar intervertebral disc, lumbar or lumbosacral intervertebral disc |
|
|
722.73 |
Intervertebral disc disorder with myelopathy |
|
HCPCS |
No code |
|
|
Type of Service |
Surgery |
|
|
Place of Service |
Inpatient |
|
Index
DeKompressor, Percutaneous Discectomy
Discectomy, Percutaneous Lumbar
Lumbar Discectomy, Percutaneous
Nucleotome, Percutaneous Discectomy
Percutaneous Lumbar Discectomy
Policy History
| Date | Action | Reason |
| 12/1/95 | Add to Surgery section | New policy |
| 04/15/02 | Replace policy | Policy reviewed without literature review; new review date only |
| 04/16/04 | Replace policy | Policy reviewed without literature, new review date only, no further review scheduled |
| 04/1/05 | Replace policy | Policy revised with literature review; now considered investigational. Rationale section rewritten, references provided |
| 03/7/06 | Replace policy | Policy revised with literature review; no change in policy statement. |
| 09/18/07 | Replace policy | Policy revised with literature review; references 7 & 8 added; no change in policy statement. |
| 11/13/08 | Replace policy | Policy revised with literature review; reference number 9 added; no change in policy statement. |
Find a Provider
Medicare
Prescription Drugs
Medicare Formulary